NGL Fine-Chem Limited
Established in 1981, NGL Fine-Chem Limited manufacturers and markets APIs, Intermediates and Finished Dosage forms for human and animal pharmaceutical product. It caters to various Indian and global companies with high quality and reliable products.
What NGL files
- Others47
- Investor Meet21
- Board Meeting8
- Important7
- PPTs7
- Credit Ratings5
NGL Fine-Chem Limited has informed the Exchange about Schedule of meet
NGL Fine-Chem Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on August 25, 2026. Further, the company has informed the Exchange regarding voting results.
NGL Fine-Chem Limited has informed the Exchange regarding Proceedings of undefined held on August 25, 2026
NGL Fine-Chem Limited has informed the Exchange regarding Corrigendum to the 45th Annual Report for the Financial Year 2025-2026
NGL Fine-Chem delivered a strong Q1FY27, sustaining demand momentum with robust volumes. Revenue from operations jumped 33.57% year-on-year to ₹139.16 Cr, and Profit After Tax (PAT) surged 99.09% year-on-year to ₹18.40 Cr. Animal APIs remain the core, contributing 95% of revenue. EBITDA margin improved to 16.73% (+620 bps YoY). The...